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The term ‘macrophage’ encompasses tissue cells that typically share dependence on the
same transcriptional regulatory pathways (e.g. the transcription factor PU.1) and growth
factors (e.g. CSF1/IL-34). They share a core set of functions that largely arise from a
uniquely high phagocytic capacity manifest in their ability to clear dying cells, pathogens
and scavenge damaged, toxic or modified host molecules. However,macrophages demon-
strate a remarkable degree of tissue-specific functionality and have diverse origins that
vary by tissue site and inflammation status. With our understanding of this diversity
has come an appreciation of the longevity and replicative capacity of tissue-resident
macrophages and thus the realisation that macrophages may persist through tissue per-
turbations and inflammatory events with important consequences for cell function. Here,
we discuss our current understanding of the parameters that regulate macrophage sur-
vival and function, focusing on the relative importance of the tissue environment versus
cell-intrinsic factors, such as origin, how long a cell has been resident within a tissue
and prior history of activation. Thus, we reconsider the view of macrophages as wholly
plastic cells and raise many unanswered questions about the relative importance of cell
life-history versus environment in macrophage programming and function.
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Introduction
The study of macrophages has been one of the most dynamic and
fast-moving fields in biology in the past 30 years. In the 1990s,
macrophages were viewed primarily as antimicrobial phagocytes
and were the poor cousins to the more popular DCs in the myeloid
cell family. This began to change with the seminal work of Sia-
mon Gordon, illustrating that macrophages responded very dif-
ferently to distinct immune signals [1]. For the next 10-15 years,
our focus was on macrophage activation states driven by local
immune signals. This led to a far greater understanding of the role
of macrophages in tissue repair and nonimmune tissue homeo-
static functions [2]. Together, these discoveries led to the accepted
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view of macrophages as remarkably plastic and flexible cells
that can change their physiology in response to environmental
cues [3].
In the 2010s, a new revolution occurred in the macrophage
field with the discovery that many if not most tissue-resident
macrophages (TRMs) had embryonic origins and were main-
tained by local self-renewal rather than recruited from the blood
[4–6]. This discovery was intimately tied to a new understanding
that macrophage proliferation plays a key role in maintenance or
expansion of specific macrophage populations. Our own contri-
bution to this revolution was the finding that in the context of
the type 2 cytokines, IL-4 and IL-13, macrophage numbers can
increase through local proliferation as an alternative strategy to
blood cell recruitment during infection or injury [7, 8].
The identification of different origins raised the question
of whether ontogeny (intrinsic signals) or the microenviron-
ment in which the cell resides (extrinsic signals) are the major
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determinant of cellular identity. In an insightful review, the
ontogeny, local environment, inflammation status, and time spent
in tissues are described as the factors that determine macrophage
phenotype [5]. It is clear, we have moved far beyond the original
descriptions of polarised macrophage activation states. This new
understanding brings enormous complexity to the macrophage
field that will require new insight to define the impact of all
these permutations on function. This review aims to highlight
many of the questions that remain unanswered in the face of our
expanding view of macrophage life history.
Tissue residency, density, and proliferation
Every tissue in the body has long-lived TRM populations, integral
to the health of that tissue, which can function independently of
blood-monocyte recruitment [5]. The level of this autonomy, how-
ever, varies dramatically between tissue sites in that some remain
entirely independent of BM contribution while other TRM pop-
ulations have high rates of replenishment from BM precursors or
low/intermediate rates. The rate of replenishment not only differs
between tissue sites but differs with age [9] and sex [10].
Tissue autonomy requires local macrophage self-renewal, a
feature of TRMs regardless of origins [4]. However, a key ques-
tion that arises, relevant to both the steady state and inflam-
matory settings is What limits the number of TRMs? Typically,
what limits cell density is the “carrying capacity” of a tissue
and is determined by multiple factors including nutrients, oxy-
gen, physical space, and critical growth factors [11]. For most
macrophages, signaling through CSF1R (the receptor for CSF-1
and IL-34) is a major determinant of survival and proliferation.
The fact that cell surface and secreted forms of CSF1 appear to
have unique roles in macrophage maintenance led to the hypoth-
esis that defined niches or territories exist, controlled by local pro-
duction of these growth factors [12]. Thus, the profile of CSF1
expressing cells may determine spatial distribution of certain TRM
populations. Zhou et al. [11] propose that macrophage prolifera-
tion is not limited by physical constraints such as contact inhibi-
tion to the same degree as stromal cells. They model a two-cell
circuit, in which cell contact between fibroblasts producing CSF1
and macrophages producing PDGF is beneficial due to optimal
growth factor exchange. In this scenario macrophage numbers
are capped at a 1:1 ratio by the number of fibroblasts [11]. In
support of this model, hepatic stellate cells, the main local pro-
ducers of CSF1 in the liver, are intimately associated with roughly
equal numbers of Kupffer cells (KC), suggesting the spatial distri-
bution of hepatic stellate cells controls the individual territories of
KC [13].
The interdependence between macrophages and stromal
CSF1-producing cells highlights an important feature of many
TRMs; they can be remarkably immobile. For example, both KC
[13] and alveolar macrophages [14] form sessile and stable inter-
actions with structural cells. Similarly, TRMs in the peritoneal
wall are stationary and evenly distributed throughout the tissue,
with tissue-protective functions performed by multiple spread-
ing pseudopods. When pseudopods are insufficient to deal with
an insult, the TRMs recruit granulocytes and monocytes [15].
Macrophage immobility is nicely illustrated in the biology of tat-
toos. Dermal macrophages are the primary store of long-term
tattoo color and the pigment remains in place due to cycles of
capture-release-recapture [16]. However, growth factor availabil-
ity from neighboring cells may not always limit TRM number
or location as macrophages can be autocrine for CSF1 [17, 18].
Alveolar macrophages in the asbestos-induced fibrotic niche pro-
duce PDGF that supports CSF1-producing fibroblasts, but these
macrophages, in both humans and mice, can themselves pro-
duce CSF1 [19]. Autocrine CSF1 may, therefore, allow fibrosis
to spread. We, therefore, need to know: Is autocrine CSF1 a
uniquely pathologic process? and what determine the limits, if
any, to macrophage expansion in disease settings. Our own data
show that constraints on macrophage numbers normally medi-
ated by CSF1 availability can be overcome by IL-4 during nema-
tode infection [7]. Whether the ability of IL-4 to override CSF1-
dependence applies in other inflammatory settings, or whether
other cytokines function similarly, remains unclear.
Numerous autonomous TRM populations, including KC [20,
21], Langerhans cells [22], peritoneal [23, 24], alveolar [9, 25–
27], and meningeal macrophages [28], can be replenished from
the BM during local inflammation. What then controls auton-
omy of TRMs? Most data suggest that engraftment of recruited
inflammatory macrophages requires loss of TRMs because replen-
ishment correlates with the degree of resident cell disappearance
that follows an inflammatory insult [9, 24] (aka the macrophage
disappearance reaction). Tran et al. [21] in a model of chronic
nonalcoholic steatosis, provide formal evidence that progres-
sive death of established KC is needed for the development of
monocyte-derived KC. Experimental depletion systems have con-
sistently demonstrated that extensive loss of TRMs provides the
space for monocytes to replenish and generates the signals for
monocytes to be recruited to tissues areas where they would not
normally migrate [13, 29]. Notably, following partial depletion,
repopulation by monocytes appears relatively inefficient com-
pared with proliferation of residual resident cells [13, 24, 29,
30]. Why this is remains unclear, but TRMs may be optimally pro-
grammed to efficiently use locally available fuels [31] and com-
pete for growth factors such as CSF1 [32]. This would explain why
in a setting of limited TRM loss (i.e. death of individuals cells)
replenishment would most likely be via proliferation of estab-
lished macrophages.
If macrophages have long-term self-renewal capacity, why do
monocytes engraft in the steady-state? One hypothesis is that
low-grade inflammation provides monocyte access. Is there minor
continual disappearance reaction in some tissues, triggered by
microbial products or mechanical stress? Fate mapping studies
suggest that replacement of embryonically derived TRMs with
monocytes reaches a plateau by 12 weeks of age in many of
these tissues [9]. This would suggest an alternative hypothesis in
which tissue growth or development is the trigger for monocyte
engraftment, consistent with the mouse uterus during pregnancy,
in which monocyte recruitment and macrophage proliferation
© 2021 The Authors. European Journal of Immunology published by
Wiley-VCH GmbH
www.eji-journal.eu
Eur. J. Immunol. 2021. 0: 1–15 HIGHLIGHTS 3
both play major roles [33]. Similar processes may occur during
cancer, when the incoming monocytes engraft into the new tissue
and then proliferate as the tumor grows in size [34, 35]. In addi-
tion, although tissue sites that promote stable sessile interactions
between macrophages and stroma are predicted to endow resis-
tance to displacement by monocytes [6], in the tattoo studies der-
mal macrophages turnover relatively rapidly from monocytes and
yet remain highly stationary [16]. Hence, it is possible that some
tissue sites are less permissive for TRM proliferation. Indeed,
dermal and gut TRM populations are reduced in monocytopenic
Ccr2–/– mice [36, 37] raising the question: What is the evolu-
tionary advantage of obligatory replenishment by monocytes?
Many intracellular pathogens preferentially infect macrophages
and, thus, monocyte replenishment at sites of high risk of
infection may allow continual elimination of pathogen reservoirs.
If monocytes can replace tissue-resident cells of embryonic ori-
gin, How important is it that a macrophage can proliferate?
Methods that analyze proliferation history demonstrate that pop-
ulation density is maintained by self-renewal rather than simply
cell longevity [10, 38–40]. In this context, the role of macrophage
proliferation is to fill an empty or reduced niche and can be
directly coupled to death of neighboring cells [41]. However, dur-
ing certain types of inflammation proliferation can occur even
when the niche is apparently full [7, 8, 42, 43]. Indeed, prolifera-
tion can lead to a dramatic increase in macrophage numbers well
beyond the steady state without monocyte input, but the func-
tional consequences of this proliferative response remain mostly
obscure. Helminth infection leads to IL-4Rα-mediated prolifera-
tive expansion in multiple tissues [44] as in tissue injury [45]. In
some settings, CSF1 can itself act to expand macrophage num-
bers above steady-state levels [34, 35, 46]. It is challenging to
establish the direct functional consequences of macrophage pro-
liferation because CSF1 or IL-4Rα inhibition have effects well
beyond macrophage proliferation. For example, macrophages in
the atherosclerotic lesion can increase in number via prolifer-
ation [47], and there is compelling evidence that TRMs which
expand through proliferation, promote tumor progression during
pancreatic cancer [48]. However, in the absence of tools to specif-
ically block macrophage proliferation, it is not possible to deter-
mine whether proliferation is a significant contributing factor to
disease. To address this question, we need to know what specifi-
cally regulates macrophage proliferation? Although closely tied
to the metabolic state of the cell [49, 50], our current understand-
ing of TRM proliferation, both mechanistically and functionally,
still remains limited (see Fig. 1).
Evidence that established and monocyte-derived resident
macrophages can differ functionally during disease will be dis-
cussed in the next section but provides a key argument as to
why proliferation may matter. Notably, in the uninflamed peri-
toneal cavity [10], the lung following influenza infection [26]
and in the liver following diet-induce inflammation [21] prolif-
eration is greater in TRMs of recent monocyte origin, a character-
istic which is reflected in the hyperproliferative state of monocyte-
derived KC repopulating an empty niche [13]. This hyperprolifer-
ative state appears to allow immature resident cells to outcompete
established resident cells in lung [26] and more rapidly repopu-
late an experimentally depleted peritoneal niche [24], yet under
steady-state conditions established TRMs are maintained [24].
What protects older resident macrophages from competition
by the more-proliferative newcomers? Proliferation is presum-
ably coupled with compensatory differences in survival and death
but to understand these dynamics, we need better tools to mea-
sure rates of survival and death. As the difference in proliferation
between immature resident cells and established resident cells can
be overcome by delivery of excess exogenous CSF1 [10], the abil-
ity to access endogenous growth factors rather than cell-intrinsic
mechanisms, such as exhaustion or senescence, may explain these
differences. However, we also still do not know whether indi-
vidual macrophage clones have an intrinsic proliferative limit.
If macrophage proliferation eventually results in telomere loss
and senescence, this will affect how they change during aging
or following chronic or repetitive inflammatory disease. The bal-
ance between “new” and “old” in a resident pool, thus, has par-
ticular relevance to aging and raises the question, addressed by
Soucie et al. [51]: How stem-like are TRMs in their self-renewal
capacity?
Cellular identity
The scale of macrophage heterogeneity is vast and new technolo-
gies have accelerated discovery of unique populations with criti-
cal tissue-specific functions [5]. These discoveries have revealed
a multilayered system (see Fig. 2), that determines the ultimate
identity, activation state, and function of a TRM. Starting with
the lineage-determining transcription factor PU. 1 (layer 1) [52],
these layers by and large require continual exposure to local con-
ditioning/activating signals, but their effect may be modified by
the prior life history of a macrophage, including ontogeny, time
of tissue residence, and history of activation/tissue residence. It
is beyond the scope of this review to cover all of these layers
in depth, but we hope to highlight key open questions regarding
the intrinsic and extrinsic features that determine cellular identity
and, thus, macrophage function.
Tissue-resident cellular identity (the second layer)
The instructive role of the tissue environment in establishing TRM
phenotype is now well established. Elegant mouse studies employ-
ing systems in which TRMs are either experimentally depleted or
tissues lacking TRMs are engrafted with different precursors have
shown that monocyte-derived cells can differentiate and largely
acquire the self-replicating and tissue-specific functional charac-
teristics of the cells they replace [29, 53–56]. Such programming
is sufficient to prevent alveolar proteinosis that would otherwise
occur in the absence of alveolar macrophages [54, 57] and, in the
case of KC to protect against intravascular infection and regulate
the response to local tissue injury [55, 56] and for microglia, to
support normal cognitive function [58].
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Figure 1. What regulates macrophage proliferation? (A) Tissue-resident macrophages (TRMs) of recent BM origin exhibit heightened proliferative
activity in some tissues and pathologies (i). However, depletion and repopulation studies demonstrate equal proliferative activity regardless of
origin (ii) suggesting proliferation is controlled by the niche. Also, both established and recently BM-derived TRM undergo extensive proliferation
on treatment with excess growth factor (ii). Thus, origin-related differences (i) are likely explained by access to distinct sources of growth factors
(GF), cofactors, or other niche signals. (B) The primary regulator of proliferation in many settings is exposure to sufficient levels of the GFs (i.e. CSF1,
IL-34, and/or CSF2). Whether a GF threshold is achieved will be determined by local and in some cases systemic GF production combined with
competition from neighboring TRM. Th2 cytokines (IL-4, IL-13, & IL-33) can drive proliferation independently of CSF1/CSF2 thereby overcoming
innate constraints on TRM population size [7, 118]. Macrophage proliferation involves multiple signaling pathways, including activation of Akt
[119, 120] and downregulation of the transcription factors Mafb and cMaf, which cause cell-cycle arrest [51], and is highly dependent on metabolic
state [50]. However, full knowledge of macrophage proliferation, is still limited. For, example: What is the role of autocrine CSF1? What tissue-specific
co-factors beyond those already identified (C1q, SP-A via Mysoin18a) [84, 121] are needed for IL-4 and IL-13-mediated proliferation? What immune or tissue
signals, such as PGE2 [49] or interferons, inhibit proliferation? The transcription factor Bhlhe40 regulates cell cycle progression specifically in peritoneal
macrophages [122]. Are equivalent tissue-specific transcriptional regulators of cell cycle found elsewhere? How does the composition of extracellular matrix
(ECM) affect proliferation? Are TRM stem-like in proliferation capacity or do they have a replicative limit?
Substantial progress has been made in understanding the
transcription factors and enhancer landscapes that regulate the
specialization of resident macrophages in many tissues [5].
Headway has also been made in identifying the drivers that
underlie specialization in certain tissues. For example, the tran-
scriptional identity and survival of peritoneal TRMs is in part
controlled by GATA6 expression in response to retinoic acid
metabolites [59, 60] produced by mesothelial cells and fibroblas-
tic stromal cells that express the transcription factor Wilms’ Tumor
1 (WT1) [61]. Retinoic acid-independent hallmark genes of peri-
toneal macrophages are also controlled by WT1+ stromal cells
but the molecular cues responsible have yet to be identified [61].
In the liver, identity of KC cells relies on the transcription factors
LXRa [62] and Id3 [63]. Expression of the Notch ligand DLL4 by
liver sinusoidal endothelial cells drives differentiation of mono-
cytes to KCs by rapidly inducing LXRa expression, and increasing
responsiveness to LXRa-inducing signals produced by hepatic stel-
late cells [13, 64]. Despite these advances and others reviewed
in [6], for most tissue sites we still do not know What signals
and molecular mechanisms imprint tissue-specific functions?
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Figure 2. What determines TRM identity? The founding layer of TRM identity is determined largely by the transcription factor PU.1 [52]. In the
unperturbed state, the next layer of identity is the tissue-specific features of TRMs that allow performance of functions essential for that organ.
This cellular identity, also under transcriptional and epigenetic control [102, 106, 123], is determined by the instructive environment of the specific
tissue. For example, serous cavity TRM function is determined by GATA6 expression, which occurs in response to retinoic acid (RA) metabolites
[59, 60] produced by WT1+ stromal cells [61]. In other tissues, the instructive environment may include not only soluble mediators but physical
properties such as extracellular matrix composition [94]. A third layer is functional alteration by systemic signals such as stress and sex hormones,
microbiome-related signals, and altered host metabolism. The fourth layer is direct immune activation of macrophages, typically by other immune
cells (e.g. IL-4 producing T-cells) or pathogen-derived molecules (e.g. LPS acting via TLR4), that may act locally or systemically, dependent on the
nature of the insult. This fourth layer is likely to be dominant because of the evolutionary imperative to protect the host from infection or injury.
Nonetheless, it is constrained by the capacity of the local cells to respond appropriately for that tissue, with the activation state of any given
macrophage reflecting not only activation signals but also local tissue (layer 2) and systemic (layer 3) signals [124].
Achieving this level of resolution is critical if we are to understand
what controls aberrant macrophage functions in disease.
The role of ontogeny
The effect of ontogeny on TRM identity is most apparent in
microglia. While BM precursors can repopulate an experimen-
tally depleted microglial niche, these cells retain long-term tran-
scriptional, epigenetic and behavioral differences, including a fail-
ure to express Sall1, a transcription factor central to microglial
identity [65–68]. The transcriptional signature of BM-derived
microglia largely overlaps with that of microglia from Sall1-
deficient mice suggesting that differential Sall1 expression largely
determines origin-related gene expression [65, 66]. Two mech-
anisms could underlie these differences. As microglia originate
exclusively from primitive yolk sac-derived macrophages [69], it
is possible that yolk sac and BM progenitors differ intrinsically
in their response to microglial niche signals [65–68]. However,
given that microglia undergo distinct maturation phases during
development [70], it is also possible that the availability of extrin-
sic CNS signals that programme for Sall1 expression change with
development, such that the adult brain is not capable of imprint-
ing the ability to express Sall1 on newly recruited cells. Both
mechanisms would rely on an element of cell-intrinsic regula-
tion to maintain gene expression in microglia. Notably, microglia
derived from yolk-sac progenitors engrafted directly into adult
brain are transcriptionally much more akin to adult microglia
than engrafted BM-derived cells [66] but never fully achieve adult
microglial Sall1 expression levels. Together, these data suggest
an overriding effect of ontogeny (intrinsic) on microglial iden-
tity, influenced by dynamic changes between the embryonic and
adult brain microenvironment (extrinsic). Where investigated in
other tissue-resident cells, the impact of ontogeny is much less
transcriptionally evident and programming is largely environment
dependent [22, 24, 29, 53–55, 71] likely reflecting that uniquely
in the brain TRMs remain fully yolk-sac derived for the life of the
animal.
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The role of time
Despite the predominant role for instructive tissue signals in
macrophage programming in most tissues [22, 24, 29, 53–55],
expression of a few genes and proteins have been considered to
be related to cell origin. The best characterization of these is the
phosphatidylserine receptor Tim4, which is associated with “res-
idency” in numerous tissue sites [5]. However, Tim4 expression
appears to be related to length of time a monocyte has been resi-
dent within the tissue. This relationship with time has been most
clearly demonstrated through kinetic analysis of Tim4 expres-
sion by monocyte-derived KC [29] and monocyte-derived peri-
toneal macrophages [24]. Expression of a number of other phago-
cytic receptors in various tissues is lower on recently recruited
monocyte-derived macrophages relative to established resident
cells (e.g. CD209 gene family, Colec12, Marco) [24, 25, 28, 29,
53–55, 71]. Where assessed (e.g. for CD209b), expression of these
phagocytic receptors also appear influenced by time-of-residency
[24, 71]. What then are broader effects of time-of-residency?
Addressing this question is important because time-of-residency
appears to have significant functional consequences. For example,
mice exhibit more severe responses to hepatic injury and increase
susceptibility to intravenous infection for a month following KC
depletion [56] despite replacement by monocytes that acquire the
bulk of KC identity within 3 days [13]. Similarly, impaired expres-
sion of CD209b by recently monocyte-derived macrophages is in
part responsible for greater susceptibility of male mice to bacterial
peritonitis [71] and is associated with defects in immune function
of monocyte-derived cells that replace meningeal macrophages
destroyed by viral infection [28]. In the lung, monocyte-derived
alveolar macrophages recruited during influenza infection retain
a transcriptional and epigenetic profile similar to that of mono-
cytes for up to a month after infection which facilitates a period
of enhanced resistance to subsequent Streptococcal pneumonia
[26]. A major functional implication of time-of-residency (and
ontogeny) is that an inflammatory event leading to substantial
integration of monocytes may be akin to resetting the clock of
TRM identity [5]. Alternatively, chronic inflammation may lead to
generation of a spectrum of cell identities related to when dur-
ing disease individual cells were recruited. Notably, monocyte-
derived KC that replace dying KC during chronic liver disease have
a reduced capacity to facilitate triglyceride storage [21] but deter-
mining whether time of residency is a factor will require under-
standing dynamics at the single-cell level.
A key unanswered question is How are time-dependent
changes regulated? Time-of-residency expression could be con-
trolled by a cell-intrinsic mechanism, perhaps similar to the “lac-
tate timer” in which macrophage activation results in a metabolic
switch with rising levels of intracellular lactate. The subsequent
histone lactylation epigenetically regulates the duration of acti-
vation [72]. Alternatively, increased time of exposure to extrin-
sic signals that differ between tissues would be consistent with
expression patterns of genes, such as Vsig4, which is time-
dependent in the peritoneal cavity but rapidly expressed in the
liver [13]. As discussed above for Sall1 expression in microglia,
the extrinsic signals may change with developmental age. Criti-
cally, tissue insult has the capacity to override a time requirement.
Monocytes recruited following severe peritoneal inflammation
[24] or helminth infection [73] rapidly upregulate Tim4, presum-
ably because those critical functions are needed. Whether intrin-
sic or extrinsic, time-dependent mechanisms would require cell-
autonomous maintenance of these features in established cells.
Competition between incoming monocytes and established
TRMs may be the underlying mechanism behind features that
appear time dependent. Monocyte-derived cells recruited follow-
ing mild peritoneal inflammation persist alongside long-term res-
ident macrophages for at least 5 months, but exhibit differen-
tial expression of almost a fifth of genes including lower levels
of the master transcriptional regulator GATA6 [24] (see Fig. 3A).
In constrast, monocytes undergo far more rapid differentiation
into residency in absence of competing resident cells [24]. Given
that peritoneal macrophages move freely in a fluid environment
[74], these data suggest established cells somehow retard tran-
scriptional development but not survival of recruited cells, per-
haps via competition for programming signals. Hence, at least in
certain tissue types, access to the parameters that control survival
(e.g. CSF1) must be separate from those that control program-
ming (e.g. retinoic acid). Consistent with competition-inhibited
maturation, under steady-state conditions, monocytes recruited
to the cavity seemingly undergo the same retarded differentia-
tion [24, 71]. The effect of competition with neighboring resident
cells for programming signals is likely to be less important where
macrophages form sessile and stable interactions with struc-
tural cells. This is supported by evidence that monocyte-derived
and incumbent resident macrophages exhibit more than 98%
transcriptional coalescence following repopulation of partially
depleted lung [53] and liver [55] macrophage niches. How and
when does competition for residency signals affect macrophage
behavior? and How does this affect subsequent susceptibility
to disease (Fig. 3B)? This question will likely be most important
in tissue environments in which the environment is more fluidic
such as the synovium or following inflammation and infection-
mediated breakdown of tissue architecture and fluid influx.
The intersection of competition and time may also play out
in the consequences of viral lung infections. Influenza infection
leads to increased resistance to subsequent Streptococcal pneu-
monia infection due to the recruitment and persistence of a
transcriptionally distinct population of monocyte-derived alveolar
macrophages poised to make high levels of IL-6 [26] (see Fig. 3C).
These monocyte-derived macrophages exhibit an epigenetic pro-
file that resembles monocytes but lose their protective capacity
within 2 months, leading the authors to propose that an epi-
genetic and time-sensitive “legacy” of monocyte origin underlies
their protective function. Perhaps surprisingly then, experimental
replacement of alveolar macrophages by monocyte-derived cells
does not lead to a state similarly poised for high IL-6 production
[26], suggesting additional adaptations in the inflamed lung envi-
ronment are important for sustaining this transient monocyte-like
state. Notably, experimental depletion of alveolar macrophages
in naïve mice is followed by re-establishment of the normal
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Figure 3. Does competition-inhibited maturation of TRM alter resistance to secondary infection? (A) Monocytes recruited to the peritoneal cav-
ity under (i) non- and (ii) mild inflammatory conditions remain in a GATA6lo state for months due to competition from enduring established
GATA6hi TRM. Transfer to a TRM-depleted cavity (iii) or severe peritoneal inflammation with complete loss of established TRM (iv) allows recruited
macrophages to acquire amature GATA6Hi phenotype. (B) GATA6lo TRM recruited during (i) non- andmild (ii) inflammatory conditions produce less
TNF and more IL-10 to challenge [24]. Notably, mild peritoneal inflammation leads to subsequent heightened susceptibility to bacterial peritonitis
concurrent with reduced neutrophil recruitment [125, 126] but it remains to be established whether the increased frequency of GATA6lo cells that
occurs postinflammation underlies this susceptibility. (C) Imaging suggests that the noninflamed lung contains a single alveolar TRM for every three
alveoli [14] but multiple macrophages per alveoli are shown here for simplicity (i). Following experimental depletion, normal macrophage numbers
are restored by recruited monocytes that become transcriptionally akin to the remaining TRMs and produce equivalent IL-6 upon challenge (ii).
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baseline density of cells [53] whereas influenza infection leads
to an increase in total population size implying the previously
distinct individual territories of alveolar macrophages may now
be infringed by recruited cells. Hence, retarded differentiation of
monocyte-derived alveolar macrophages following infection could
be due to direct competition with established cells (see Fig. 3D).
If so, it will be important to understand why infection leads
to prolonged increase in alveolar macrophage numbers com-
pared to steady state? Addressing this question may help resolve
why a previous study [75] found that infection using the same
strain of influenza resulted in increased susceptibility rather than
resistance to bacterial pneumonia, since this earlier study found
no evidence that infection caused a prolonged increase alveolar
macrophage number.
Systemic signals that alter identity and function (the
third layer)
Long-range signals that programme TRM function include those
produced by microbiota, such as metabolites like short-chain
fatty acids [76, 77] and lactate [78], and microbiota-associated
molecular patterns [79]. These can have overlapping effects
on macrophages in multiple tissues, for example, regulating
the tissue localization of microglia [76] and KC [79]. Sex also
significantly affects TRM identity and function but this appears
tissue-specific [71, 80]. How does sex determine macrophage
function? Effects of sex could occur through systemic or
tissue-specific regulation of hormones (extrinsic), regulation by
sex-chromosome complement (intrinsic), or indirect pathways
such as regulation of microbiota [81]. Notably, female microglia
retain a more effective ability to protect against ischemic stroke
following adoptive transfer into male brains [80] and microbiota
influence microglial transcriptional identity in a sex-specific
manner [82]. It is likely that integration of systemic signals with
tissue-specific or time/competition-related signals, as discussed
above, combine to determine the ultimate identity of TRMs.
These studies highlight the complexity of defining TRM identity
or function based on key transcription factors alone.
Activation (the fourth layer)
A large body of literature on macrophage activation status reflect
the view of macrophages as effector cells for antimicrobial func-
tions (M1—classical activation) or tissue reparative, antihelminth
functions (M2—alternative activation). Although widely acknowl-
edged as an oversimplification, the fundamental idea remains;
that acute signals during an immune response, typically T-cell
derived but also pathogen and damage-associated molecular pat-
terns, act to instruct macrophages to perform key host-protective
functions. Critically, these activation signals differ from the tis-
sue conditioning factors that determine cell identity described
above. Activation is acute, and likely to be dominant over iden-
tity. Nonetheless, cell identity will determine the capacity of the
cell to respond to specific activation signals, not least due to recep-
tor expression that may be altered by tissue-specific conditioning
signals. For example, recently recruited macrophages respond dif-
ferently to IL-4 than TRMs [83] so prior programming is impor-
tant in the quality of the macrophage response to stimuli. In addi-
tion, unique tissue conditions also control activation response. For
example, lung surfactants, the unique metabolic environment and
epithelial cell-derived signals, determine the capacity of airway
macrophages to respond to IL-4 [84, 85], and proinflammatory
signals [86]. Thus, a central question for the field is: How does the
interaction of tissue-specific cell identity with activation signals
translate to function?
Innate memory
There is increasing evidence that prior history of inflammation
and infection can significantly alter the progression of future
disease [87], and that macrophages play a central role in this
altered state [26, 75, 88, 89]. Coupled with this, the relation-
ship of cell identity to activation state, discussed above, has raised
the question to what degree does prior history determine the
macrophage response to future stimuli? This question lies at the
heart of the extensive debate on innate memory or “training,” a
concept that was largely developed out of the myeloid cell field
[90, 91]. Divangahi, Netea and colleagues [92] recently distin-
guished trained immunity from other forms of adaptation, by the
requirement for the immune activation status to return to basal
levels after removal of the stimulus, while epigenetic modifica-
tion of chromatin and DNA persist. Although this definition may
work on an individual cell level, on a tissue level this is chal-
lenging, as there are few circumstances in which a tissue chal-
lenged by infection or injury returns fully to baseline. For exam-
ple, extracellular matrix composition can be substantially altered
with consequences for the subsequent immune response [93, 94]
and inflammation can also lead to long-term alteration of the com-
position of immune cells within a tissue [87]. Equally, epigenetic
modifications underpinning altered tissue responses may reside
in other resident cells such as epithelial stem cells [95] and NK
cells [96, 97]. These complexities mean the term “training” as
currently defined may have limited utility. Semantics aside, the

Influenza infection can lead to the protracted increase in total alveolar TRM numbers due to persistence of established cells and endurance of
monocyte-derived macrophages (iii). In this setting, recruited cells retain an epigenetic and transcriptional legacy of their monocyte origin and
provide enhanced resistance to secondary bacterial challenge through elevated IL-6 production [26]. However, whether retention of the monocyte-
signature arises from competition-inhibited maturation remains unclear. (D) We propose a model whereby the effect of differentiation of mono-
cytes in the presence of enduring resident TRM is tissue-specific, with recently recruited cells acquiring an inflammatory function between that of
established TRM and monocytes.
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major outstanding question is to what extent do macrophage-
intrinsic epigenetic modifications give rise to innate memory in
tissues? or does reprogramming of other tissue cells or structures
dictate divergent responses of macrophages to future activation?
This review is written in the midst of the Covid-19 pandemic and
understanding the consequences to lung function of prior viral
infection [87] is relevant to the millions who have been infected.
What is the in vivo evidence that there is cell-intrinsic repro-
gramming of macrophage responses to new stimuli? Trans-
fer experiments provide growing evidence that TRMs retain the
imprint of prior inflammation. For example, approximately 1
month after resolution of infection with a lung migrating nema-
tode, alveolar macrophages can confer heightened protection to
naïve mice [98]. Influenza infection leads to a long-term state
of immunosuppression and increased susceptibility to bacterial
pneumonia, which can be conferred to naïve mice by transfer
of alveolar macrophages and is reversed by replacement of this
compartment from the BM [75]. Although these studies suggest
long-term cell-intrinsic functional changes to TRMs, we do not
know: where or when are TRMs epigenetically altered dur-
ing an inflammatory response? More recently, LPS injection has
been shown to affect the severity of subsequent neuropatholo-
gies with epigenetic alterations in microglial enhancer reper-
toires strongly implicated [99]. Pulmonary adenovirus infection
results in enhanced resistance to Streptococcal pneumonia for at
least 4 months, which can be conferred to naïve mice by trans-
fer of the resident alveolar macrophages [88]. These studies
provide strong evidence that cell-intrinsic alterations to estab-
lished TRM can occur in the inflamed tissue itself. However, dur-
ing an inflammatory response, TRMs can be replaced by BM-
derived cells raising the question: Do key events in education
of monocyte-derived macrophages occur following their entry
into the tissue or up-stream in the BM? In a seminal study,
pulmonary gammaherpes virus infection led to long-term pro-
tection against development of lung allergy due to the replace-
ment of resident alveolar macrophages by long-lived monocyte-
derived cells [27]. Only BM-derived TRMs recruited during active
infection adopted the immunosuppressive phenotype. However,
consistent with some programming at the BM stage, circulating
monocytes exhibited elevated MHCII expression and IL-10 pro-
duction during the acute phase of infection [27]. Very strong evi-
dence that infection can programme hematopoietic stem cells to
generate myeloid cells with altered function comes from a study
showing that BCG infection bestows an enhanced capacity to kill
Mycobacterium tuberculosis upon BM-derived macrophages for at
least 4-5 months postinfection [100]. This effect was associated
with altered histone acetylation and methylation status of BM-
derived macrophages and inherited by newly generated mono-
cytes following bone marrow transplant. Taken together, these
studies argue for functionally important cell-intrinsic changes to
macrophages that alter their innate response to secondary chal-
lenge. Yet to more fully understand the cause and consequence
of this reprogramming, we need to ask: How does the effect of
the primary stimulus (e.g. strength, quality) on subsequent
responses differ depending on the stage of macrophage differ-
entiation? (i.e. BM precursors/monocytes vs recruited inflamma-
tory macrophage vs established TRM).
In our effort to understand the innate mechanisms involved in
altered macrophage function, we are in danger of forgetting the
potent role of the adaptive immune response, raising the ques-
tion: How does adaptive immunity contribute to innate mem-
ory? It remains unclear whether macrophage education by non-
adaptive immune mechanisms plays a major physiological role
in the context of a fully functioning adaptive immune response.
Indeed, the adaptive immune response itself may be the initial
“training” event. For example, T-cell-derived IFN-γ may imprint
long-term epigenetic changes on myeloid cells [88]. Licensing
of innate memory by adaptive immunity in infection settings
makes certain sense not only given its dominant role in dictating
macrophage activation states but also the stringent checkpoints
applied to adaptive immunity. Does adaptive immunity regu-
late the extent of innate macrophage training, perhaps via T-
regulatory cells? Once innate memory is established, it is easy to
imagine that memory T cells will be the dominant determinant of
macrophage activation status during most secondary challenges.
Nonetheless, epigenetic alterations due to prior exposure will fine-
tune macrophage response to these activation signals.
What is plasticity?
Plasticity is often hailed as a trademark of macrophages and yet
what this actually means, and more important its functional con-
sequences, are often unclear. In their original discussion of plastic-
ity, Stout and Suttles [101] proposed that the macrophage lineage
displays extreme phenotypic heterogeneity because of their ability
to functionally adapt to changes in their tissue microenvironment.
In this model, macrophage identity or activation state is purely
the product of environmental signals at a particular point in time.
The circumstances that lead to cell identity (ontogeny, time, tissue
conditioning factors) are distinct from more acute factors (T-cell
derived cytokines, DAMPS, and microbial products) that drive the
current activation state. As discussed above, macrophage func-
tion and identity can change due to prior inflammatory events.
Inherent in our realization of the effects of ontogeny, time-of-
residency and prior inflammatory exposure is to acknowledge that
macrophage plasticity is not unrestricted but limited by cell life
history. Indeed, one of the challenges of studying plasticity is the
term is now used to describe fundamentally different processes.
Plasticity or “reversibility” of cell identity
As discussed above, TRM identity is dependent on continual expo-
sure to local conditioning signals. For example, while retinoic
acid is a major signal controlling the transcriptional identity of
serous cavity macrophages, this programme is largely reversible
by vitamin A deficiency [59] and the retinoic acid-driven gene
programme is lost following in vitro culture [60, 102]. Simi-
larly, microglia removed from the brain lose their transcriptional
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programme but can fully reacquire it upon re-engraftment, sug-
gesting the brain is replete with necessary factors to sustain and
reinduce homeostatic microglial gene expression in a cell already
preconditioned [66]. TRMs in multiple tissues are programmed
not to mount an inflammatory response to nucleic acid on clear-
ance of dying cells, but this tolerance is rapidly lost on culture in
vitro [103]. So while it is clear that a resident macrophage loses
identity when it leaves the tissue niche, to what degree can resi-
dent cell identity be reprogrammed to a new environment? This
question is not just academic. Resident serous cavity macrophages
have been reported to migrate into injured organs [104], and the
niche itself may change with inflammation/fibrosis.
However, the finding that serous cavity macrophages move
into new tissues has been challenged [105], and experimental
transfer studies suggest TRMs do not survive well in all ectopic
environments. For example, while a small number of peritoneal
macrophages can establish when transferred to a macrophage-
deficient lung, they fail to repopulate the empty lung, in contrast
to the proficient ability of fetal liver or BM-derived monocytes,
or yolk-sac macrophages [54]. A similar study found peritoneal
macrophages acquired only 70% of the transcriptional identity of
alveolar macrophages [106]. These data suggest that the plasticity
of mature tissue-resident cells is limited in comparison to mono-
cytes, but why is not known. They may lack the ability to migrate
to all available niches in the lung, although in this study, alveolar
macrophages were capable of engrafting, suggesting that the peri-
toneal macrophages have lost the ability to respond to new tissue-
specific signals. Indeed, the fundamental question is What deter-
mines the limits of identity plasticity? The answer likely lies, at
least in part, in the consequences of time spent in the tissues, and
the epigenetic changes and limitations that may impose. When
peritoneal macrophages move into endometrial lesions they lose
expression of GATA6 [107] as they do in culture. In contrast, other
peritoneal TRM genes that are RA-independent, such as CXCL13,
are not lost in culture [61, 102]. Greater understanding the epige-
netic regulation of these genes during inflammation or in ectopic
environments is needed [102]. Long-term resident cells may have
more limited plasticity because they no longer express key recep-
tors or because monocyte enhancers are no longer poised to
respond [106]. Once again, these are not just academic ques-
tions, since established peritoneal macrophages are less effective
at preventing endometrial lesion growth than recently monocyte-
derived resident macrophages [107].
Plasticity or “reversibility” of activation state
References to macrophage plasticity in the literature are fre-
quently based not on cell identity as discussed above, but on the
ability of macrophages to move reversibly on a spectrum (or a
wheel) between M1/M2 activation states [3, 108]. The potential
for reprogramming is particularly relevant in the context of infec-
tion, where consecutive infections with diverse pathogens and the
requirement to repair infection damage are major evolutionary
drivers. Our understanding of plasticity, however, has been heavily
drawn from in-vitro or ex-vivo studies in which cells are removed
and repolarized [101, 109]. While in-vivo studies strongly impli-
cate the ability of macrophages to alter their activation state, stud-
ies that demonstrate plasticity on a single-cell level are rare. In
a coinfection study, peritoneal TRMs activated and expanded by
IL-4 (M(IL-4)) during helminth infection, reduce type 2 markers
and produce iNOS in response to subsequent Salmonella infection
[89]. Using RELMα+ as marker for M(IL-4), individual RELMα+
cells are equal or better able to produce iNOS than RELMα-cells in
response to bacteria. Another finding was that activation plasticity
was not, as often assumed, bidirectional. While microbial signals
could reprogramme a strongly M(IL-4) polarized macrophage, the
reverse was not true [89], consistent with a report that suppres-
sion of mitochondrial function in M1 cells prevents M(IL-4) repo-
larization [110]. So not surprisingly, there are constraints on plas-
ticity but What determines the limits of activation plasticity?
While these constraints may be largely epigenetic, cellular loca-
tion can also influence the ability of a macrophage to be repro-
grammed. Dermal macrophages retain a full M(IL-4) phenotype in
the face of a potent Th1-tissue environment caused by Leishmania
major infection and appear protected from the Th1-stimuli by IL-
4 producing eosinophils [111]. It remains unclear whether these
cells are rendered unresponsive to proinflammatory/Th1 stimuli
or simply spatially detached or physically protected from these
signals. Indeed, one of the greatest limitations to understand-
ing the extent of reversibility to activate in vivo is our inability
to definitively measure which stimuli individual cells have been
exposed to both during initial activation and subsequent activa-
tion. Perhaps, a more fundamental question arises: How impor-
tant is activation plasticity at the single-cell level? Despite clear
evidence of TRM plasticity from M2 to M1 as described above,
monocyte influx is the dominant protective response to Salmonella
infection, regardless of TRM numbers or phenotype [89]. Indeed,
to understand the contribution of macrophages to specific disease
outcomes, the practical question remains What are the distinct
host-protective functions of TRMs vs. newly recruited cells?
There is certainly no simple paradigm that answers this question.
Incoming monocyte-derived cells can be either more proinflam-
matory [26, 89] or more immune suppressive [73, 112] than the
existing TRMs. These differences may be linked to the cells pro-
liferative state [50], innate memory as discussed above, and com-
petition between these populations (see Fig. 3B and D)
Conclusions
Irrespective of all the question we have highlighted, understand-
ing the role macrophages in disease remains of primary impor-
tance and we want to pay homage to the plethora of articles
defining new functions of macrophages in different contexts and
different tissues. While we cannot do justice to the large num-
ber of new articles, it is important to highlight that we are now
beginning to answer one of the most pressing questions in the
field: What are the functional consequences of macrophage life
history? Whether the cell is blood derived, short-term resident, or
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long-term resident matters because therapeutic approaches can be
targeted. It is critical to remember that the vast majority of work
cited in this review was performed in C57BL/6 mice because of
the utility of this strain. However, the focus on a single genetic
background means gene by environment interactions are largely
missed in our current approaches. In addition to expanding our
animal studies to include a greater range of natural conditions,
more experimental work in humans [113, 114], where ethically
possible, is needed. Fortunately, the field is currently benefitting
enormously from single-cell technologies, which are dramatically
enhancing our ability to identify myeloid populations that are con-
served between mice and humans [19, 115–117].
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